See If You Qualify For The vacc-gsk-mat Research Trial
The purpose of this research study is to evaluate the lot to lot safety consistency of RSV maternal vaccine and to evaluate the reactogenicity and immunogenicity of a single intramuscular dose of GSK Biologicals’ investigational RSV maternal vaccine given alone or in co-administration with a single intramuscular dose of seasonal influenza vaccine D-QIV.
Qualified Participants will receive:
- Study-related vaccine at no cost
- Study-related medical exams at no cost
- Compensation up to $250 for time and travel
How It Works
Subscribe To Our Newsletter
Subscribe to learn more about our clinical research trials, current and upcoming studies.